Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience | Swiss Medical Weekly
Fibroscan™ (Sound Based Elastography) | Gastro Health - Framingham
Hepatic steatosis on FibroScan with controlled attenuation parameter... | Download Scientific Diagram
Fibroscan - Dr Douglas Samuel
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter - ScienceDirect
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography - Myers - 2012 - Liver International - Wiley Online Library
Fibroscan.dr quiyum | PPT
Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library
Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
Diagnostics | Free Full-Text | Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area
Changes in CAP (dB/m) and weight (Kg) in the overall population (A, B). | Download Scientific Diagram
Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North America - ScienceDirect
COMPARISON OF THE BASELINE CHARACTERISTICS OF PATIENTS WITH CAP < 220... | Download Table
Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin Resistance
What Is a Fibroscan?
Fibrosis: Development
![PDF] Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/aeff7274892fbe6500c35da9cc35da059a5956a8/4-Table2-1.png "PDF] Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease | Semantic Scholar")
PDF] Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease | Semantic Scholar
Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease - Nan Xu, Qinxiu Xie, Jiang Li, Yufeng Gao, Xu
SciELO - Brasil - MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY MEASUREMENT OF
Controlled Attenuation Parameter (CAP) and liver stiffness cut-offs... | Download Scientific Diagram
EPOS™ - C-01454
Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience
Parameters associated with NAFLD (CAP ≥ 248 dB/m). | Download Scientific Diagram
NON-OBESE NAFLD IS ASSOCIATED WITH HIGHER SCD14 CONCENTRATIONS IN ADULTS WITH HIV
Factors associated with CAP ! 238 dB/m vs. CAP | Download Table
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension | Digestive Diseases and Sciences
